ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.
Em Crescimento
A empresa está em fase de crescimento, com a receita anual mais recente totalizando US$ 6.77M.
Sobreavaliada
O PE mais recente da empresa é -0.02, em uma faixa percentil alta de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 303.07K ações, uma redução de 50.33% em relação ao trimestre anterior.
Mantido por The Vanguard
O Super Investidor The Vanguard possui 53.19K ações desta empresa.
Alta Atividade de Mercado
A empresa tem maior interesse dos investidores, com uma taxa de giro de 20 dias de 4.02.